Shaun Rodriguez
Direttore/Membro del Consiglio presso Amplifybio LLC
Profilo
Shaun Rodriguez currently works as a Director at Amplifybio LLC.
Posizioni attive di Shaun Rodriguez
Società | Posizione | Inizio |
---|---|---|
Amplifybio LLC
Amplifybio LLC Miscellaneous Commercial ServicesCommercial Services Amplifybio LLC is a drug development and commercialization partner that provides preclinical toxicology, safety, and pharmacology testing services to advance therapeutics for the betterment of human health. The company is based in West Jefferson, OH and has subsidiaries in the United States. The company was launched out of Battelle in 2021 and has since expanded its services to include R&D and drug characterization services, as well as customizable manufacturing suites for lease. Amplifybio's clients benefit from decades of experience in drug development, safety testing, and manufacturing support services, which help to reduce risks, timelines, and costs of bringing life-saving cures to patients. The company was founded in 2021, and the CEO is J. Kelly Ganjei. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Amplifybio LLC
Amplifybio LLC Miscellaneous Commercial ServicesCommercial Services Amplifybio LLC is a drug development and commercialization partner that provides preclinical toxicology, safety, and pharmacology testing services to advance therapeutics for the betterment of human health. The company is based in West Jefferson, OH and has subsidiaries in the United States. The company was launched out of Battelle in 2021 and has since expanded its services to include R&D and drug characterization services, as well as customizable manufacturing suites for lease. Amplifybio's clients benefit from decades of experience in drug development, safety testing, and manufacturing support services, which help to reduce risks, timelines, and costs of bringing life-saving cures to patients. The company was founded in 2021, and the CEO is J. Kelly Ganjei. | Commercial Services |
- Borsa valori
- Insiders
- Shaun Rodriguez